You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

AMINOCAPROIC ACID IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Aminocaproic Acid In Plastic Container, and what generic alternatives are available?

Aminocaproic Acid In Plastic Container is a drug marketed by Hospira and is included in one NDA.

The generic ingredient in AMINOCAPROIC ACID IN PLASTIC CONTAINER is aminocaproic acid. There are six drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the aminocaproic acid profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Aminocaproic Acid In Plastic Container

A generic version of AMINOCAPROIC ACID IN PLASTIC CONTAINER was approved as aminocaproic acid by LUITPOLD on December 1st, 1987.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for AMINOCAPROIC ACID IN PLASTIC CONTAINER?
  • What are the global sales for AMINOCAPROIC ACID IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for AMINOCAPROIC ACID IN PLASTIC CONTAINER?
Summary for AMINOCAPROIC ACID IN PLASTIC CONTAINER
Drug patent expirations by year for AMINOCAPROIC ACID IN PLASTIC CONTAINER
Recent Clinical Trials for AMINOCAPROIC ACID IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Minia UniversityPhase 3
NYU Langone HealthN/A
Assiut UniversityPhase 4

See all AMINOCAPROIC ACID IN PLASTIC CONTAINER clinical trials

Pharmacology for AMINOCAPROIC ACID IN PLASTIC CONTAINER
Drug ClassAntifibrinolytic Agent
Physiological EffectDecreased Fibrinolysis

US Patents and Regulatory Information for AMINOCAPROIC ACID IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira AMINOCAPROIC ACID IN PLASTIC CONTAINER aminocaproic acid INJECTABLE;INJECTION 070010-001 Mar 9, 1987 AP RX No Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

AMINOCAPROIC ACID IN PLASTIC CONTAINER Market Analysis and Financial Projection Experimental

Aminocaproic Acid Market Dynamics and Financial Trajectory

Introduction to Aminocaproic Acid

Aminocaproic acid, also known as epsilon-aminocaproic acid (EACA), is an amino acid derivative that plays a crucial role in preventing excessive bleeding. It works by inhibiting the activity of plasminogen activators, thereby promoting clot formation and reducing the breakdown of fibrin, the protein responsible for clotting. This makes it especially useful in surgeries, trauma care, and medical treatments for conditions like hemophilia or bleeding disorders[1].

Medical Applications of Aminocaproic Acid

Aminocaproic acid is widely used in medical treatments to prevent and control bleeding. It is particularly effective in surgeries, trauma care, and in managing bleeding disorders such as hemophilia and von Willebrand disease. The drug is available in various forms, including tablets and oral solutions, and is often used in combination with other treatments like factor replacement therapy[5].

Industrial Applications of Aminocaproic Acid

Beyond its medical uses, aminocaproic acid has significant applications in the chemical and materials industries. It is used in the production of synthetic resins, adhesives, and coatings, as well as in textile manufacturing. The growing demand for sustainable, efficient, and cost-effective chemical solutions is driving interest in aminocaproic acid’s applications beyond its traditional medical use[1].

Market Growth Drivers

Increasing Demand in Healthcare

The global healthcare sector is experiencing a rise in demand for hemostatic agents, particularly in regions like Asia-Pacific, Latin America, and Africa, where healthcare infrastructure is expanding. This increased demand is driven by the need for effective bleeding control in surgeries and trauma care, positioning aminocaproic acid as a key player in these markets[1].

Industrial and Chemical Applications

The shift towards more sustainable and eco-friendly chemical solutions is driving the demand for aminocaproic acid in industrial applications. Its use in producing biodegradable plastics, resins, and coatings is gaining traction, making it an attractive option for companies looking to adopt greener production methods[1].

Innovations in Drug Delivery Systems

Advancements in drug delivery systems are opening new avenues for aminocaproic acid in medical treatments. Researchers are exploring its potential in controlled-release drug formulations and targeted therapies for bleeding disorders, which could further expand its use in personalized medicine[1].

Market Trends

Collaboration and Mergers

The aminocaproic acid market is witnessing increased collaboration between healthcare companies, pharmaceutical manufacturers, and industrial players. Recent mergers and acquisitions are positioning companies to take advantage of new growth opportunities in both medical and industrial sectors. For instance, companies are investing in joint ventures to expand aminocaproic acid’s use in industrial applications[1].

Sustainability Focus

As industries worldwide increasingly prioritize sustainability, the demand for bio-based and environmentally friendly chemicals is growing. Aminocaproic acid, being a relatively eco-friendly chemical compound, fits into this trend and is expected to see increased demand in applications like biodegradable materials[1].

Financial Trajectory

Market Size and Growth

The global aminocaproic acid market is projected to grow significantly. From 2023 to 2032, the market size is expected to increase from USD 1.2 billion to USD 1.8 billion, exhibiting a compound annual growth rate (CAGR)[4].

Sales and Price Analysis

Historical sales data and price analysis indicate steady growth in the aminocaproic acid market. Sales forecasts suggest continued growth, with the market expected to expand in various countries including the US, Germany, France, Italy, Spain, UK, Japan, Brazil, Russia, India, China, and Australia[2].

Investment Opportunities

The expanding use of aminocaproic acid across diverse sectors presents a range of investment opportunities for businesses and venture capitalists. Investors can focus on companies engaged in the production, research, and development of aminocaproic acid for its medical and industrial applications. Emerging markets with growing healthcare demand and the development of new aminocaproic acid formulations are particularly promising areas for investment[1].

Challenges and Mitigation

Supply Chain Stability

Despite the bankruptcy and closure of Akorn Pharmaceuticals, one of the manufacturers of aminocaproic acid, the market is not expected to face a shortage. Other manufacturers have indicated their ability to meet market demands, and regulatory bodies like the FDA are closely monitoring the situation to prevent any supply issues[5].

Regional Market Dynamics

Global Market Expansion

The aminocaproic acid market is expanding globally, with significant growth anticipated in regions such as Asia-Pacific, Latin America, and Africa. These regions are experiencing an increase in healthcare spending and infrastructure development, which is driving the demand for hemostatic agents and surgical products[1].

Country-Specific Trends

Sales and price data vary by country, with different regions showing unique growth trends. For example, countries in North America and Europe have established markets, while emerging economies are showing rapid growth due to increasing healthcare needs and industrial development[2].

Competitive Landscape

The aminocaproic acid market is characterized by a competitive landscape with multiple players. Companies are focusing on expanding their product portfolios, investing in research and development, and forming strategic partnerships to capture a larger market share. The competitive landscape is also influenced by regulatory factors, with companies working closely with regulatory bodies to ensure compliance and maintain market stability[1].

Future Prospects

Innovations and New Formulations

The future of the aminocaproic acid market looks promising with ongoing innovations in drug delivery systems and industrial applications. New formulations and custom solutions for specific industries are expected to drive the next wave of market growth. The focus on sustainable and eco-friendly solutions will continue to be a key driver for the market[1].

Emerging Markets

Emerging markets are expected to play a significant role in the future growth of the aminocaproic acid market. As healthcare infrastructure expands in these regions, the demand for hemostatic agents and surgical products will increase, providing substantial investment opportunities for manufacturers of aminocaproic acid-based products[1].

Key Takeaways

  • Growing Demand in Healthcare: The increasing need for effective bleeding control in surgeries and trauma care is driving the demand for aminocaproic acid.
  • Industrial Applications: The use of aminocaproic acid in producing synthetic resins, adhesives, and coatings, as well as in textile manufacturing, is gaining traction.
  • Sustainability Focus: The shift towards sustainable and eco-friendly chemical solutions is boosting the demand for aminocaproic acid.
  • Innovations in Drug Delivery: Advancements in drug delivery systems are opening new avenues for aminocaproic acid in medical treatments.
  • Investment Opportunities: The market offers significant investment opportunities, particularly in emerging markets and in the development of new formulations.

FAQs

What is aminocaproic acid used for?

Aminocaproic acid is used to prevent excessive bleeding in medical treatments, particularly during surgeries and trauma care. It also has industrial applications in the production of synthetic resins, adhesives, and coatings, as well as in textile manufacturing[1].

Is there a risk of aminocaproic acid shortage?

Despite the bankruptcy of one manufacturer, Akorn Pharmaceuticals, the market is not expected to face a shortage. Other manufacturers have indicated their ability to meet market demands, and regulatory bodies are closely monitoring the situation[5].

What are the key drivers of the aminocaproic acid market?

The key drivers include the increasing demand for hemostatic agents in healthcare, the growing use in industrial applications, and the focus on sustainable and eco-friendly chemical solutions[1].

What are the future prospects for the aminocaproic acid market?

The market is expected to grow significantly driven by innovations in drug delivery systems, new formulations, and the expanding use in emerging markets. The focus on sustainability will continue to drive demand[1].

Which regions are expected to see significant growth in the aminocaproic acid market?

Emerging regions such as Asia-Pacific, Latin America, and Africa are expected to see significant growth due to increasing healthcare spending and infrastructure development[1].

Sources

  1. Market Research Intellect: Aminocaproic Acid Market on the Rise: Key Trends and Future Opportunities.
  2. Business Wire: Aminocaproic Acid Sales, Price Analysis, & Sales Forecasts 2016-2021.
  3. Market Research Intellect: Global Aminocaproic Acid Injection Market Size, Trends and Forecasts.
  4. Dataintelo: Aminocaproic Acid Market Research Report 2032.
  5. NBDF: Aminocaproic Acid Production Update.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.